The Effects of Ellagic Acid Upon Brain Cells: A Mechanistic View and Future Directions

Overview

Journal Neurochem Res

Specialties Chemistry
Neurology

Date 2016 Feb 6

PMID 26846140

Citations 22

Authors

Marcos Roberto de Oliveira

Affiliations

Soon will be listed here.

Abstract

Ellagic acid (EA, 2,3,7,8-tetrahydroxy-chromeno; C14H6O8) is a polyphenol derived from fruits (pomegranates, berries) and nuts. EA exhibits antioxidant capacity and induces anti-inflammatory actions in several mammalian tissues. EA has been characterized as a possible neuroprotective agent, but the number of reports is still limited to conclude whether and how EA exerts neuroprotection in humans. In this regard, performing additional studies considering the potential beneficial and/or toxicological roles for EA on brain cells would be an important step towards fully understanding of when and how EA may be securely utilized by humans as a neuroprotective agent. The aim of the present work is to discuss data related to the neuronal and glial effects of EA and the mechanisms underlying such events. Moreover, future directions are suggested as a potential guide to be utilized by researchers interested in investigating the neuronal and glial actions of EA hereafter.

Citing Articles

Targeting natural antioxidant polyphenols to protect neuroinflammation and neurodegenerative diseases: a comprehensive review.

Jalouli M, Rahman M, Biswas P, Rahman H, Harrath A, Lee I Front Pharmacol. 2025; 16:1492517.

PMID: 39981183 PMC: 11840759. DOI: 10.3389/fphar.2025.1492517.

Exploring the synergistic potential of pomegranate fermented juice compounds against oxidative stress-induced neurotoxicity through computational docking and experimental analysis in human neuroblastoma cells.

Akter R, Morshed M, Awais M, Kong B, Oh S, Oh J Heliyon. 2024; 10(15):e34993.

PMID: 39157308 PMC: 11327604. DOI: 10.1016/j.heliyon.2024.e34993.

A Critical Appraisal of the Protective Activity of Polyphenolic Antioxidants against Iatrogenic Effects of Anticancer Chemotherapeutics.

Purgatorio R, Boccarelli A, Pisani L, De Candia M, Catto M, Altomare C Antioxidants (Basel). 2024; 13(1).

PMID: 38275658 PMC: 10812703. DOI: 10.3390/antiox13010133.

Ellagic acid alleviates motor, cognitive and hippocampal electrical activity deficits in the male rats with 2-vessel occlusion cerebral ischemia/reperfusion.

Hassonizadeh Falahieh K, Sarkaki A, Edalatmanesh M, Gharib Naseri M, Farbood Y Avicenna J Phytomed. 2023; 13(6):651-664.

PMID: 38106628 PMC: 10719720. DOI: 10.22038/AJP.2023.22787.

Synthetic and Natural Bioactive Molecules in Balancing the Crosstalk among Common Signaling Pathways in Alzheimer's Disease: Understanding the Neurotoxic Mechanisms for Therapeutic Intervention.

Shah A, Ahad Mir P, Adnan M, Patel M, Maqbool M, Mir R ACS Omega. 2023; 8(43):39964-39983.

PMID: 37929080 PMC: 10620788. DOI: 10.1021/acsomega.3c05662.

References

Salimi A, Roudkenar M, Sadeghi L, Mohseni A, Seydi E, Pirahmadi N . Ellagic acid, a polyphenolic compound, selectively induces ROS-mediated apoptosis in cancerous B-lymphocytes of CLL patients by directly targeting mitochondria. Redox Biol. 2015; 6:461-471. PMC: 4588415. DOI: 10.1016/j.redox.2015.08.021. View

Green D, Galluzzi L, Kroemer G . Cell biology. Metabolic control of cell death. Science. 2014; 345(6203):1250256. PMC: 4219413. DOI: 10.1126/science.1250256. View

Sompol P, Xu Y, Ittarat W, Daosukho C, St Clair D . NF-kappaB-associated MnSOD induction protects against beta-amyloid-induced neuronal apoptosis. J Mol Neurosci. 2006; 29(3):279-88. View

Arulmozhi V, Pandian K, Mirunalini S . Ellagic acid encapsulated chitosan nanoparticles for drug delivery system in human oral cancer cell line (KB). Colloids Surf B Biointerfaces. 2013; 110:313-20. DOI: 10.1016/j.colsurfb.2013.03.039. View

Anitha P, Vidya Priyadarsini R, Kavitha K, Thiyagarajan P, Nagini S . Ellagic acid coordinately attenuates Wnt/β-catenin and NF-κB signaling pathways to induce intrinsic apoptosis in an animal model of oral oncogenesis. Eur J Nutr. 2011; 52(1):75-84. DOI: 10.1007/s00394-011-0288-y. View

Yu Y, Wang Z, Liu C, Chen C . Ellagic acid inhibits IL-1beta-induced cell adhesion molecule expression in human umbilical vein endothelial cells. Br J Nutr. 2007; 97(4):692-8. DOI: 10.1017/S0007114507666409. View

Lee W, Ou H, Hsu W, Chou M, Tseng J, Hsu S . Ellagic acid inhibits oxidized LDL-mediated LOX-1 expression, ROS generation, and inflammation in human endothelial cells. J Vasc Surg. 2010; 52(5):1290-300. DOI: 10.1016/j.jvs.2010.04.085. View

Nohynek L, Alakomi H, Kahkonen M, Heinonen M, Helander I, Oksman-Caldentey K . Berry phenolics: antimicrobial properties and mechanisms of action against severe human pathogens. Nutr Cancer. 2006; 54(1):18-32. DOI: 10.1207/s15327914nc5401_4. View

Gauliard B, Grieve D, Wilson R, Crozier A, Jenkins C, Mullen W . The effects of dietary phenolic compounds on cytokine and antioxidant production by A549 cells. J Med Food. 2008; 11(2):382-4. DOI: 10.1089/jmf.2007.593. View

10.

Vieira O, Meilhac O, Basile J, Laranjinha J, Almeida L, Salvayre R . Effect of dietary phenolic compounds on apoptosis of human cultured endothelial cells induced by oxidized LDL. Br J Pharmacol. 1998; 123(3):565-73. PMC: 1565185. DOI: 10.1038/sj.bjp.0701624. View

11.

Alfredsson C, Ding M, Liang Q, Sundstrom B, Nanberg E . Ellagic acid induces a dose- and time-dependent depolarization of mitochondria and activation of caspase-9 and -3 in human neuroblastoma cells. Biomed Pharmacother. 2013; 68(1):129-35. DOI: 10.1016/j.biopha.2013.08.010. View

12.

Garcia-Nino W, Zazueta C . Ellagic acid: Pharmacological activities and molecular mechanisms involved in liver protection. Pharmacol Res. 2015; 97:84-103. DOI: 10.1016/j.phrs.2015.04.008. View

13.

Goodwin E, Atwood W, DiMaio D . High-throughput cell-based screen for chemicals that inhibit infection by simian virus 40 and human polyomaviruses. J Virol. 2009; 83(11):5630-9. PMC: 2681952. DOI: 10.1128/JVI.00203-09. View

14.

Rojanathammanee L, Puig K, Combs C . Pomegranate polyphenols and extract inhibit nuclear factor of activated T-cell activity and microglial activation in vitro and in a transgenic mouse model of Alzheimer disease. J Nutr. 2013; 143(5):597-605. PMC: 3738232. DOI: 10.3945/jn.112.169516. View

15.

Lei F, Xing D, Xiang L, Zhao Y, Wang W, Zhang L . Pharmacokinetic study of ellagic acid in rat after oral administration of pomegranate leaf extract. J Chromatogr B Analyt Technol Biomed Life Sci. 2003; 796(1):189-94. DOI: 10.1016/s1570-0232(03)00610-x. View

16.

Kim S, Nishimoto S, Bumgardner J, Haggard W, Gaber M, Yang Y . A chitosan/beta-glycerophosphate thermo-sensitive gel for the delivery of ellagic acid for the treatment of brain cancer. Biomaterials. 2010; 31(14):4157-66. DOI: 10.1016/j.biomaterials.2010.01.139. View

17.

Fjaeraa C, Nanberg E . Effect of ellagic acid on proliferation, cell adhesion and apoptosis in SH-SY5Y human neuroblastoma cells. Biomed Pharmacother. 2008; 63(4):254-61. DOI: 10.1016/j.biopha.2008.07.093. View

18.

Li Y, Dai Y, Sun J, Xiang Y, Yang J, Dai S . Neuroglobin Attenuates Beta Amyloid-Induced Apoptosis Through Inhibiting Caspases Activity by Activating PI3K/Akt Signaling Pathway. J Mol Neurosci. 2015; 58(1):28-38. DOI: 10.1007/s12031-015-0645-z. View

19.

Waalkes M . Cadmium carcinogenesis in review. J Inorg Biochem. 2000; 79(1-4):241-4. DOI: 10.1016/s0162-0134(00)00009-x. View

20.

Mandal S, Ahuja A, Shivapurkar N, Cheng S, Groopman J, Stoner G . Inhibition of aflatoxin B1 mutagenesis in Salmonella typhimurium and DNA damage in cultured rat and human tracheobronchial tissues by ellagic acid. Carcinogenesis. 1987; 8(11):1651-6. DOI: 10.1093/carcin/8.11.1651. View